MacroGenics, Inc. · SWB:M55

MacroGenics, Inc. financial statements

MacroGenics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue149.5M150.0M58.7M151.9M77.4M104.9M64.2M60.1M157.7M91.9M
Cost of revenue0847.0K619.0K3.35M2.65M00190.8M147.2M122.1M
Gross profit106.3M136.0M49.0M144.6M73.0M97.8M62.0M60.1M155.5M86.6M
Research and development147.2M177.2M166.6M207.0M214.6M193.2M195.3M190.8M147.2M122.1M
Selling, general and administrative39.2M71.0M52.2M58.9M63.0M42.7M46.1M40.5M32.7M29.8M
Operating income-72.8M-110.6M-168.2M-121.4M-202.8M-131.1M-177.2M-171.2M-22.1M-60.0M
Depreciation and amortization7.17M7.54M9.64M11.9M11.3M12.0M12.3M9.16M7.23M7.61M
EBITDA-65.7M-103.0M-158.6M-109.6M-191.5M-119.1M-164.9M-162.0M-14.9M-52.4M
Interest expense8.51M1.11M1.43M0000000
Income before tax-75.3M-66.0M-9.06M-119.8M-202.1M-129.7M-151.8M-171.5M-19.6M-58.5M
Income tax-672.0K944.0K00000000
Net income-74.6M-67.0M-9.06M-119.8M-202.1M-129.7M-151.8M-171.5M-19.6M-58.5M
Earnings per share, basic-1.18-1.07-0.15-1.95-3.37-2.47-3.10-4.05-0.54-1.69
Earnings per share, diluted-1.18-1.07-0.15-1.95-3.37-2.47-0.54-1.69

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents57.2M182.8M101.0M108.9M123.5M181.1M126.5M220.1M211.7M84.1M
Short-term investments132.7M18.8M128.8M45.5M120.1M91.4M89.3M12.7M93.4M192.9M
Receivables427.0K4.31M10.4M56.2M10.4M23.1M12.7M29.6M13.6M2.76M
Inventory7.91M01.22M1.45M4.39M010-7.99M
Current assets219.9M217.5M251.3M222.2M279.6M312.6M239.8M269.1M322.3M283.9M
Property, plant and equipment2.10M18.1M21.8M29.6M37.7M42.2M48.2M56.7M50.0M18.0M
Goodwill00
Total assets256.8M261.7M298.4M280.5M335.2M378.7M312.5M332.1M373.9M311.3M
Accounts payable3.26M5.01M6.44M4.90M15.5M8.03M4.31M4.00M2.45M4.00M
Current liabilities43.1M55.5M56.1M48.6M74.6M50.7M45.2M59.9M49.8M27.3M
Long-term debt00
Total debt106.8M37.5M34.0M34.8M25.5M29.2M30.6M298.0K1.89M
Total liabilities201.3M145.6M145.8M138.5M95.6M82.9M81.9M89.3M74.6M42.5M
Shareholders' equity55.6M116.1M152.6M142.0M239.6M295.9M230.6M242.9M299.2M268.8M
Shares outstanding63.3M62.8M62.1M61.7M61.3M56.2M49.0M42.4M36.9M34.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-81.0M-68.4M-78.2M-87.0M-143.8M-111.9M-134.3M-153.2M14.4M-43.7M
Capital spending-1.91M-3.71M-1.76M-3.62M-6.20M-5.91M-4.29M-25.0M-29.4M-11.4M
Free cash flow-83.0M-72.1M-80.0M-90.6M-150.0M-117.8M-138.6M-178.2M-15.0M-55.1M
Cash from investing-114.1M149.3M-80.1M70.7M-36.6M-7.79M-79.4M56.6M77.9M-70.2M
Cash from financing69.5M960.0K150.4M1.66M122.8M174.3M120.0M105.0M35.3M1.85M
Dividends paid00
Share buybacks-306.0K1.08M117.8M-2.01M0-260.0K-40.0K-39.0K
Change in cash-125.6M81.9M-7.93M-14.6M-57.7M54.7M-93.7M8.40M127.6M-112.1M